PMGC Holdings Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Graydon Bensler
- Full Time Employees
- 2
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 120 Newport Center Drive Newport Beach CA United States of America 92660
- IPO Date
- Nov 21, 2023
- CIK
- 0001840563
- Website
- pmgcholdings.com
- Similar Companies
- Business
- PMGC Holdings Inc. operates as a diversified holding company focused on acquiring, managing, and growing cash-flowing businesses primarily in the manufacturing, biopharmaceutical, research, and investment sectors. The company, through its wholly owned subsidiaries, offers biopharmaceutical development including the lead asset EL-22, a first-in-class engineered probiotic therapy designed to preserve muscle mass during weight loss treatments such as GLP-1 receptor agonists; medical scientific research and development activities via PMGC Research Inc.; multi-strategy investment, lending, and portfolio management through PMGC Capital LLC; custom IT packaging solutions for electronics, data centers, and technology manufacturers via Pacific Sun Packaging Inc.; and precision CNC machining, aerospace, and defense manufacturing services through AGA Precision Systems LLC. PMGC Holdings maintains operations in the United States, targeting commercial, industrial, and healthcare customers with scalable, compliant products and services. Incorporated in 2020 and headquartered in Newport Beach, California, the company was formerly known as Elevai Labs Inc. and underwent a strategic reorganization and name change in December 2024. Recent developments include the sale of its Elevai Skincare subsidiary to Carmell Corporation in January 2025 for immediate financial benefit and future royalties; completion of the acquisition of Pacific Sun Packaging Inc. in July 2025 for $1.148 million plus earnout to enhance exposure to semiconductor and AI infrastructure; acquisition of AGA Precision Systems LLC in July 2025 and subsequent purchase of Indarg Engineering Inc. in Q4 2025 to expand aerospace and defense capabilities; partnerships such as with Yuva Biosciences for AI-powered therapies and Modulant Biosciences for animal model studies on EL-22; positive FDA feedback supporting an IND submission for Phase 2 trials of EL-22; new US patent filings for EL-22 and EL-32 programs; multiple financing activities including $8.0 million public offering in 2024, $1.9 million and $1.67 million warrant inducements in 2025, and a $1.48 million registered direct offering; and reverse stock splits in March and August 2025 to maintain Nasdaq listing compliance.
PMGC Holdings Signs Non-Binding Letter of Intent to Acquire Majority Stake in U.S.-Based Precision Machining Manufacturing Company Serving Aerospace, Space, Defense, and Semiconductor Markets
GB Capital Ltd. Co-Advises on the Acquisition of A&B Aerospace Inc.
PMGC Holdings Inc. [NASDAQ: ELAB] Reports Q1 2026 Results and Files Form 10-Q; Total Assets Reach Over $26.0 Million, Up 102% from Year-End 2025 and 193% Year-over-Year
PMGC Holdings (NASDAQ: ELAB) Acquires A&B Aerospace, Inc.
UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions related to GLP-1 Use, Sarcopenia, Muscle Disuse Atrophy, and Certain Neurological Disorders
NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans
NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans
NorthStrive Defense Tech Acquires Patented GPS-Denied Autonomous Drone Navigation Technology Option, Built for Defense and Counter-Unmanned Aircraft Systems
Univest Securities, LLC Announces a $40 Million Equity Line Facility for its Client PMGC Holdings, Inc. (NASDAQ: ELAB)
SVM Machining, Inc. Signs Long-Term Agreement to Supply Mission-Critical Aerospace and Defense Components to Turbo-Jet Products Co., Inc.
PMGC Holdings, Inc. (Nasdaq: ELAB) Secures $40 Million Equity Purchase Facility Agreement: Announces Ability To Accelerate M&A Strategy Currently Focused on Acquiring Aerospace and Defense Manufacturing Companies
What's Going On With PMGC Holdings Stock?
NorthStrive Biosciences Announces U.S. Arrival of EL-32 Working Cell Bank and Initiation of Manufacturing Optimization for Dual Myostatin Assets Targeting Muscle Preservation with GLP-1 Therapies in Collaboration with Modulant Biosciences
Why PMGC Holdings Stock Is Falling Friday?
Pacific Sun Packaging to Showcase Solutions at ITAD Europe 2026, Targeting Global Market Expansion
Why Is PMGC Holdings Stock Gaining Thursday?
AGA Precision Systems Signs Second Long-Term Supply Agreement to Manufacture Aerospace and Defense Components for a Tier 1 Firm
PMGC Holdings Inc. [NASDAQ: ELAB] Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition Strategy
What's Going On With PMGC Stock Monday?
NorthStrive Defense Tech Acquires Multi-Domain Drone Payload Technology Option for Defense and Commercial Applications